Complete BLA submission for Deramiocel
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 24 Sep 2024
- Due
- 31 Dec 2024
- Delivered
- December 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Aim to complete BLA submission ~Q4 2024”
What we found
Evidence strength A What the grades mean
Capricor Therapeutics completed the full BLA submission for Deramiocel in December 2024, meeting its goal of completing the submission by the end of the fourth quarter of 2024.
-
A Capricor Therapeutics, Inc. 10-K filed 2025-03-26
“We completed the full submission of the BLA in December 2024” ✓ confirmed on the page
Market reaction: the shares moved -11.2% against the S&P 500 over the three sessions around the disclosure (25 Mar 2025 to 28 Mar 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- BLA submission
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Capricor Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-CAPR-002557 · Corrections policy